Marked elevation of C-reactive protein (CRP) (whose expression is propelled by IL-6) also serves as a biomarker to assess the severity of clinical CRS [3] and studies have used CRP and ferritin as surrogate markers of hyperinflammation [6-7]. The gene discussed is IL6; the disease is congenital rubella syndrome.